{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:25:42Z","timestamp":1771485942745,"version":"3.50.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Olanzapine is a second-generation antipsychotic increasingly used in emergency medicine for many indications. Literature on its use in children is sparse. Our objectives were to describe the use, safety, and efficacy of olanzapine in pediatric emergency patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A structured chart review was performed of patients 18 years old or younger receiving olanzapine from 2007 to 2016 in the emergency department of a pediatric level I trauma center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 285 children received olanzapine. Mean age was 16.4 years (range, 9\u201318 years); 121 were male (42.8%). Primary indications for olanzapine included agitation (n = 166, 58.3%), headache (n = 58, 20.4%), nausea\/vomiting\/abdominal pain (n = 37, 12.5%), unspecified pain (n = 20, 7%), and other (n = 4, 1.4%). Route of olanzapine administration was intramuscular (n = 160, 56%; median dose, 10 mg; range, 2.5\u201320), intravenous (n = 101, 36%; median dose, 5 mg; range, 1.25\u20135), and oral (n = 24, 8%; median dose, 10 mg; range, 5\u201310). For agitated patients, 28 (17%) received another sedative within 1 hour. For headache patients, 5 (8.6%) received another analgesic. For gastrointestinal complaints, 5 patients (13.5%) received another analgesic\/antiemetic. Adverse respiratory events were hypoxia (pulse oximetry reading, in percentage, &lt;92%; n = 7, 2.4%), supplemental oxygen placement (n = 9, 3.2%), and intubation (n = 2, 0.7%). No patient died or had a dysrhythmia. One patient experienced dystonia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Olanzapine seems safe when used for a variety of conditions in pediatric emergency patients. It may be effective for acute agitation, primary headache, and gastrointestinal complaints.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pec.0000000000001231","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T15:12:04Z","timestamp":1499785924000},"page":"70-76","source":"Crossref","is-referenced-by-count":26,"title":["The Use, Safety, and Efficacy of Olanzapine in a Level I Pediatric Trauma Center Emergency Department Over a 10-Year Period"],"prefix":"10.1097","volume":"36","author":[{"given":"Jon B.","family":"Cole","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Hennepin County Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren R.","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hennepin County Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley M.","family":"Strobel","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hennepin County Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane R.","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hennepin County Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Nahum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc L.","family":"Martel","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hennepin County Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2017,7,11]]},"reference":[{"key":"bib2-20231107","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.annemergmed.2016.08.008","article-title":"A prospective observational study of patients receiving intravenous and intramuscular olanzapine in the emergency department","volume":"69","year":"2017","journal-title":"Ann Emerg Med"},{"key":"bib3-20231107","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1553-2712.2008.00197.x","article-title":"Olanzapine versus droperidol for the treatment of primary headache in the emergency department","volume":"15","year":"2008","journal-title":"Acad Emerg Med"},{"key":"bib4-20231107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/acem.12842","article-title":"A large retrospective cohort of patients receiving intravenous olanzapine in the emergency department","volume":"23","year":"2016","journal-title":"Acad Emerg Med"},{"key":"bib5-20231107","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annemergmed.2012.07.118","article-title":"Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"61","year":"2013","journal-title":"Ann Emerg Med"},{"key":"bib6-20231107","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.annemergmed.2016.07.033","article-title":"Midazolam-droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial","volume":"69","year":"2017","journal-title":"Ann Emerg Med"},{"key":"bib7-20231107","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/j.2055-2335.2011.tb00681.x","article-title":"Intravenous olanzapine for acute agitation in the emergency department","volume":"41","year":"2011","journal-title":"J Pharm Pract Res"},{"key":"bib9-20231107","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0196-0644(96)70264-0","article-title":"Chart reviews in emergency medicine research: where are the methods?","volume":"27","year":"1996","journal-title":"Ann Emerg Med"},{"key":"bib10-20231107","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","year":"2009","journal-title":"J Biomed Inform"},{"key":"bib11-20231107","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.annemergmed.2015.03.016","article-title":"The safety and effectiveness of droperidol for sedation of acute behavioral disturbance in the emergency department","volume":"66","year":"2015","journal-title":"Ann Emerg Med"},{"key":"bib12-20231107","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1197\/aemj.9.12.1402","article-title":"A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population","volume":"9","year":"2002","journal-title":"Acad Emerg Med"},{"key":"bib13-20231107","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/PEC.0b013e3181d6d9f2","article-title":"Droperidol use in pediatric emergency department patients","volume":"26","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"bib15-20231107","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/10903120590891723","article-title":"Discontinuation of droperidol for the control of acutely agitated out-of-hospital patients","volume":"9","year":"2005","journal-title":"Prehosp Emerg Care"},{"key":"bib16-20231107","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11095-006-0070-7","article-title":"Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis","volume":"23","year":"2006","journal-title":"Pharm Res"},{"key":"bib17-20231107","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00002018-200528010-00003","article-title":"Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death","volume":"28","year":"2005","journal-title":"Drug Saf"},{"key":"bib18-20231107","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.jcp.0000104913.75206.62","article-title":"A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition","volume":"24","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"bib19-20231107","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/JCP.0000000000000142","article-title":"Lack of effect of risperidone or olanzapine dose reduction on metabolic parameters, prolactin, and corrected QT interval in stable patients with schizophrenia","volume":"34","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"bib20-20231107","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/2045125314546484","article-title":"Olanzapine induced Q-Tc shortening","volume":"4","year":"2014","journal-title":"Ther Adv Psychopharmacol"},{"key":"bib22-20231107","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2190\/U99G-XDML-0GRG-BYE0","article-title":"Severe cardiovascular side effects of olanzapine in an elderly patient: case report","volume":"33","year":"2003","journal-title":"Int J Psychiatry Med"},{"key":"bib23-20231107","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0091270002042001013","article-title":"Hypotension and bradycardia in a healthy volunteer following a single 5 mg dose of olanzapine","volume":"42","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"bib24-20231107","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/YIC.0b013e32805aedf5","article-title":"Olanzapine overdose: a series of analytically confirmed cases","volume":"22","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"bib25-20231107","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1089\/cap.2006.16.671","article-title":"A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents","volume":"16","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"bib26-20231107","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1753-2000-3-9","article-title":"Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study","volume":"3","year":"2009","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"bib27-20231107","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1542\/peds.2009-2337","article-title":"Treatment of children with migraine in emergency departments: national practice variation study","volume":"126","year":"2010","journal-title":"Pediatrics"},{"key":"bib28-20231107","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1542\/peds.2014-2432","article-title":"A comparison of acute treatment regimens for migraine in the emergency department","volume":"135","year":"2015","journal-title":"Pediatrics"},{"key":"bib29-20231107","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1553-2712.2001.tb01147.x","article-title":"Droperidol vs. prochlorperazine for benign headaches in the emergency department","volume":"8","year":"2001","journal-title":"Acad Emerg Med"},{"key":"bib30-20231107","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00003495-199243040-00003","article-title":"Pharmacological agents affecting emesis. A review (Part II)","volume":"43","year":"1992","journal-title":"Drugs"},{"key":"bib31-20231107","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1515725","article-title":"Olanzapine for the prevention of chemotherapy-induced nausea and vomiting","volume":"375","year":"2016","journal-title":"N Engl J Med"},{"key":"bib32-20231107","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/pbc.25286","article-title":"Olanzapine for treatment and prevention of acute chemotherapy-induced vomiting in children: a retrospective, multi-center review","volume":"62","year":"2015","journal-title":"Pediatr Blood Cancer"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000001231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T21:03:44Z","timestamp":1699391024000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000001231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,11]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000001231","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"value":"1535-1815","type":"electronic"},{"value":"0749-5161","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7,11]]}}}